TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TELA TELA Bio, Inc.

Trading 01-13 12:22:05 EST

1.05

-0.01

-0.94%

High1.07	Low1.04	Vol19.55K
Open1.07	D1 Closing1.06	Amplitude2.83%
Mkt Cap46.76M	Tradable Cap22.75M	Total Shares44.53M
T/O20.51K	T/O Rate0.09%	Tradable Shares21.67M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TELA","market":"US","secType":"STK","nameCN":"TELA Bio, Inc.","latestPrice":1.05,"timestamp":1768324870392,"preClose":1.06,"halted":0,"volume":19553,"delay":0,"floatShares":21665700,"shares":44530500,"eps":-0.885237,"marketStatus":"Trading","change":-0.01,"latestTime":"01-13 12:22:05 EST","open":1.07,"high":1.07,"low":1.04,"amount":20507.8746656,"amplitude":0.028302,"askPrice":1.05,"askSize":484,"bidPrice":1.02,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.885237,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":1.06,"preHourTrading":{"tag":"盘前","latestPrice":1.05,"preClose":1.06,"latestTime":"08:59 EST","volume":682,"amount":720.5999724000001,"timestamp":1768312773305},"postHourTrading":{"tag":"盘后","latestPrice":1.06,"preClose":1.06,"latestTime":"16:50 EST","volume":59,"amount":62.54,"timestamp":1768254610754},"volumeRatio":0.812747,"impliedVol":1.7492,"impliedVolPercentile":0.259},"requestUrl":"/m/hq/s/TELA","defaultTab":"news","newsList":[{"id":"2593316224","title":"Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly","url":"https://stock-news.laohu8.com/highlight/detail?id=2593316224","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593316224?lang=en_us&edition=fundamental","pubTime":"2025-12-23 00:56","pubTimestamp":1766422619,"startTime":"0","endTime":"0","summary":"Becton Dickinson BDX.N has been sued by a rival medical device manufacturer for allegedly thwarting competition in the U.S. market for surgical hernia mesh and causing patients and care providers to pay higher prices.The lawsuit by Tela Bio Inc TELA.O, filed on Friday in the federal court in Philadelphia, claims Becton Dickinson leveraged its dominance in two key product categories — permanent hernia mesh and resorbable hernia mesh — to exclude Tela Bio’s OviTex product.Hernia repairs are among the most widely performed operations nationwide, amounting to $12 billion annually, according to the lawsuit.Pennsylvania-based Tela Bio alleges Becton Dickinson violated antitrust law by punishing hospitals and other healthcare systems for buying Tela Bio’s product and using long-term contracts to lock purchasers into buying solely from Becton Dickinson.The case is Tela Bio Inc v. Becton, Dickinson & Co et al, U.S. District Court, Eastern District of Pennsylvania, No. 2:25-cv-07189.R.I. jury or","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nL6N3XS0AC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0433182093.SGD","IE00BFXG1179.USD","LU0985320562.USD","LU1150488135.SGD","LU0878866978.SGD","BK4198","LU1894683264.USD","LU0130518102.USD","LU0289739343.SGD","LU1854104046.USD","LU1059921491.USD","LU1489326972.SGD","LU0289961442.SGD","LU1571399168.USD","BK4082","LU0985489474.SGD","BK4585","LU1894683348.USD","LU1854103824.USD","LU0072461881.USD","LU0006061336.USD","LU0648000940.SGD","BK4504","LU0162691827.USD","LU0511384066.AUD","BK4588","LU0477156797.USD","LU0068578508.USD","LU1201861165.SGD","LU1150488218.USD","TELA","LU0266013472.USD","BDX","LU0130103400.USD"],"gpt_icon":0},{"id":"2591008689","title":"TELA Bio Grants Restricted Stock Units to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2591008689","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591008689?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:05","pubTimestamp":1765573510,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. has granted inducement restricted stock units covering 3,600 shares of its common stock to three newly-hired employees. The restricted stock units will vest in equal annual installments over four years, contingent upon each individual's continued service with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via GlobeNewswire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL2fdwTx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4198","LU2210149790.SGD","NDAQ","BK4588","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4585","SG9999014021.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","SG9999014013.SGD","IE00BGHQF748.EUR","TELA","LU0314104364.USD","BK4112","LU2210150020.SGD"],"gpt_icon":0},{"id":"2590450542","title":"TELA Bio Inc - Registers 2,000,000 Shares for Resale - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2590450542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590450542?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:11","pubTimestamp":1765541513,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nFWN3XI0H8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"gpt_icon":0},{"id":"2588177470","title":"TELA Bio Is Maintained at Buy by Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2588177470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588177470?lang=en_us&edition=fundamental","pubTime":"2025-12-02 01:13","pubTimestamp":1764609180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 01, 2025 12:13 ET (17:13 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2584925399","title":"Tela Bio Appoints William Plovanic To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2584925399","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584925399?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:27","pubTimestamp":1763569659,"startTime":"0","endTime":"0","summary":"Nov 4 (Reuters) - TELA Bio Inc ::*TELA BIO APPOINTS WILLIAM PLOVANIC TO BOARD OF DIRECTORS  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 03-NOV-202521:05:02.603 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD5dtM60:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"gpt_icon":0},{"id":"2584944381","title":"TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584944381","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584944381?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:30","pubTimestamp":1763559000,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Nov.  19, 2025   -- TELA Bio, Inc. , a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in Piper Sandler’s 37th Annual Healthcare Conference. TELA’s management is scheduled to present at Piper Sandler’s 37th Annual Healthcare Conference at 2:30 pm ET on December 3rd, 2025. Interested parties can access the live and archived webcast at ir.telabio.com. About TELA Bio, Inc.TELA Bio, Inc.  is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190923/0/en/TELA-Bio-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4137","XLV","XBI","HCSG","QID","QLD","NVIW.SI","SQQQ",".IXIC","TQQQ","BK4588","PSQ","TELA","QQQ","USAW.SI","USJW.SI","MNQmain","BK4198","TSYW.SI","BK4585","LABU","BK4581","NQmain","LU0128526141.USD"],"gpt_icon":0},{"id":"2584693413","title":"TELA Bio Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2584693413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584693413?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:02","pubTimestamp":1763467320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 18, 2025 07:02 ET (12:02 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2584346919","title":"Strategic Initiatives and Financial Adjustments Underpin Buy Rating for TELA Bio Despite Short-term Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2584346919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584346919?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:56","pubTimestamp":1763466962,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Caitlin Cronin maintained a Buy rating on TELA Bio yesterday and set a price target of $4.00. Caitlin Cronin has given he...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/strategic-initiatives-and-financial-adjustments-underpin-buy-rating-for-tela-bio-despite-short-term-challenges-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/strategic-initiatives-and-financial-adjustments-underpin-buy-rating-for-tela-bio-despite-short-term-challenges-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA"],"gpt_icon":0},{"id":"2584787939","title":"Tela Bio price target lowered to $4 from $7 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2584787939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584787939?lang=en_us&edition=fundamental","pubTime":"2025-11-18 19:15","pubTimestamp":1763464546,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on Tela Bio (TELA) to $4 from $7 and keeps a Buy rating on the shares. The firm said they posted a challe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-4-from-7-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-4-from-7-at-canaccord-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA","BK4198"],"gpt_icon":0},{"id":"2584674973","title":"EW Healthcare Partners Fund 2 Acquires Common Shares of TELA Bio Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2584674973","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584674973?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:26","pubTimestamp":1763414807,"startTime":"0","endTime":"0","summary":"EW Healthcare Partners Fund 2, L.P. and other reporting beneficial owners have reported the acquisition of common shares of TELA Bio Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL1lvM0F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EW Healthcare Partners Fund 2 Acquires Common Shares of TELA Bio Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"gpt_icon":0},{"id":"2584671798","title":"TELA Bio Grants Stock Options and Restricted Units to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2584671798","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584671798?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:05","pubTimestamp":1763413508,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. has announced the approval of inducement grants to newly hired employees. Seventeen new hires will receive restricted stock units covering a total of 30,200 shares of common stock, vesting in equal annual installments over four years. Additionally, one employee has been granted an option to purchase 25,000 shares of common stock at an exercise price of $1.19 per share, with the options vesting over four years: 25% after the first year and the remaining shares vesting in equal monthly installments over the following 36 months. The grants were made with a grant date of November 10, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TELA Bio Inc. published the original content used to generate this news brief via GlobeNews","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL5vNLzn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","TELA","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","LU2095319765.USD","LU2210149790.SGD","BK4198","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","BK4112","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2584749856","title":"TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584749856","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584749856?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:05","pubTimestamp":1763413500,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Nov.  17, 2025  (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA Bio\") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3189577/0/en/TELA-Bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ",".IXIC","QID","NVIW.SI","QLD","USJW.SI","TQQQ","MNQmain","BK4198","NQmain","TELA","TSYW.SI","PSQ","USAW.SI"],"gpt_icon":1},{"id":"2583829536","title":"TELA Bio Secures $70 Million Term Loan Facility from Perceptive Credit Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2583829536","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583829536?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:47","pubTimestamp":1763156855,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. has entered into a new Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP, establishing a senior secured term loan facility of up to $70 million. The agreement includes an initial loan of $60 million to be funded on November 14, 2025, and an additional delayed draw loan of $10 million available subject to certain conditions. The facility matures on November 14, 2030, and will accrue interest at an annual rate equal to a margin of 7.85% plus the greater of the Reference Rate or 4.25%. As part of the agreement, TELA Bio will issue warrants to Perceptive to purchase up to 2,000,000 shares of common stock at an exercise price of $1.11, with additional warrants available in connection with the delayed draw loan. The facility is secured by a first lien on substantially all of TELA Bio's assets.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL5mtlgV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"gpt_icon":0},{"id":"2583500150","title":"TELA Bio Is Maintained at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2583500150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583500150?lang=en_us&edition=fundamental","pubTime":"2025-11-14 23:39","pubTimestamp":1763134740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TELA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2025 10:39 ET (15:39 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"gpt_icon":0},{"id":"2583508716","title":"Tela Bio price target lowered to $1.25 from $2 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2583508716","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583508716?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:51","pubTimestamp":1763121113,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Matt O’Brien lowered the firm’s price target on Tela Bio (TELA) to $1.25 from $2 and keeps a Neutral rating on the shares. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-1-25-from-2-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tela-bio-price-target-lowered-to-1-25-from-2-at-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA","BK4198"],"gpt_icon":0},{"id":"2583650668","title":"Positive Sentiment Still Eludes TELA Bio, Inc. (NASDAQ:TELA) Following 26% Share Price Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=2583650668","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583650668?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:18","pubTimestamp":1763119131,"startTime":"0","endTime":"0","summary":"The TELA Bio, Inc. ( NASDAQ:TELA ) share price has fared very poorly over the last month, falling by a substantial 26...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tela/tela-bio/news/positive-sentiment-still-eludes-tela-bio-inc-nasdaqtela-foll","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tela/tela-bio/news/positive-sentiment-still-eludes-tela-bio-inc-nasdaqtela-foll","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SQQQ",".IXIC","QID","NVIW.SI","QLD","USJW.SI","TQQQ","MNQmain","BK4198","NQmain","TELA","TSYW.SI","PSQ","USAW.SI"],"gpt_icon":1},{"id":"2583517310","title":"TELA Bio Reports Q3 Revenue Growth and New Credit Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2583517310","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583517310?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:35","pubTimestamp":1763069739,"startTime":"0","endTime":"0","summary":"An update from TELA Bio ( ($TELA) ) is now available. On November 13, 2025, TELA Bio reported its third-quarter financial results, highlighting a 9...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-reports-q3-revenue-growth-and-new-credit-facility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-reports-q3-revenue-growth-and-new-credit-facility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA"],"gpt_icon":0},{"id":"2583512638","title":"Press Release: TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512638","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512638?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:21","pubTimestamp":1763068860,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Nov. 13, 2025  -- TELA Bio, Inc. , a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the pricing of an underwritten registered direct offering of 4,189,000 shares of its common stock at a price of $1.11 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase 7,523,000 shares of common stock at an offering price of $1.1099 per pre-funded warrant, which represents the per share offering price for the shares of common stock less the $0.0001 per share exercise price. The gross proceeds to TELA from the offering, before deducting underwriting discounts and estimated offering expenses, are expected to be approximately $13.0 million, assuming no exercise of the pre-funded warrants. The offering is expected to close on or about November 17, 2025, subject to the satisfaction of customary closing conditions.TELA Bio, Inc. is a commercial-stage medical technol","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"gpt_icon":0},{"id":"2583147511","title":"TELA Bio Inc. reports Q3 revenue of $20.7 million, up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583147511","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583147511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067676,"startTime":"0","endTime":"0","summary":"TELA Bio Inc. reported third quarter 2025 revenue of $20.7 million, representing a 9% increase compared to the same period in 2024. Gross profit for the quarter was $14.0 million, or 67.5% of revenue, up from $12.9 million, or 67.8% of revenue, in the third quarter of 2024. The revenue growth was primarily driven by new customer additions, increased international sales, and the U.S. launch of larger-sized OviTex PRS configuration, partially offset by a decrease in average selling prices for hernia products due to a higher share of smaller-sized units. The company revised its full year 2025 revenue guidance to at least 16% growth over 2024. As of September 30, 2025, cash and cash equivalents totaled $29.7 million. TELA Bio also closed a credit facility for up to $70.0 million with Perceptive Advisors, consisting of an initial $60.0 million loan and an additional $10.0 million available upon meeting certain conditions. The credit facility matures on November 14, 2030, and is interest-onl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL6YNG09:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4198","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4588","TELA","NDAQ","IE00BKPKM429.USD","BK4585","LU2210149790.SGD","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","LU0314104364.USD"],"gpt_icon":0},{"id":"2583511913","title":"TELA Bio Q3 Gross Profit USD 13.969 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511913?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:01","pubTimestamp":1763067661,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXEF8E77:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telabio.com","stockEarnings":[{"period":"1week","weight":-0.0364},{"period":"1month","weight":-0.0783},{"period":"3month","weight":-0.2886},{"period":"6month","weight":-0.4673},{"period":"1year","weight":-0.6228},{"period":"ytd","weight":-0.1017}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.017358},{"month":2,"riseRate":0.5,"avgChangeRate":-0.003028},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.21226},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.057639},{"month":5,"riseRate":0.833333,"avgChangeRate":0.116033},{"month":6,"riseRate":0.5,"avgChangeRate":0.060581},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.037817},{"month":8,"riseRate":0.5,"avgChangeRate":-0.029417},{"month":9,"riseRate":0.5,"avgChangeRate":-0.04117},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.071357},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.011933},{"month":12,"riseRate":0.571429,"avgChangeRate":0.074086}],"exchange":"NASDAQ","name":"TELA Bio, Inc.","nameEN":"TELA Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELA Bio, Inc.,TELA,TELA Bio, Inc.股票,TELA Bio, Inc.股票老虎,TELA Bio, Inc.股票老虎国际,TELA Bio, Inc.行情,TELA Bio, Inc.股票行情,TELA Bio, Inc.股价,TELA Bio, Inc.股市,TELA Bio, Inc.股票价格,TELA Bio, Inc.股票交易,TELA Bio, Inc.股票购买,TELA Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction